Literature DB >> 18278475

Inhibitory effect of the anorexic compound oleoylethanolamide on gastric emptying in control and overweight mice.

Gabriella Aviello1, Isabel Matias, Raffaele Capasso, Stefania Petrosino, Francesca Borrelli, Pierangelo Orlando, Barbara Romano, Francesco Capasso, Vincenzo Di Marzo, Angelo A Izzo.   

Abstract

Gastric emptying regulates food intake. Oleoylethanolamide (OEA), an endogenous acylethanolamide chemically related to the endocannabinoid anandamide, inhibits food intake, but its effect on gastric emptying is unknown. Here, we investigated the effect and the role of OEA on gastric emptying in mice fed either a standard (STD) or a high-fat diet (HFD) for 14 weeks. Gastric emptying was reduced by OEA, but not by its saturated analog, palmitoylethanolamide. The effect of OEA was unaffected by rimonabant (cannabinoid CB1 receptor antagonist), SR144528 (cannabinoid CB2 receptor antagonist), 5'-iodoresiniferatoxin (transient receptor potential vanilloid type 1 antagonist), or MK886 (peroxisome proliferator-activated receptor-alpha) antagonist. Compared to STD mice, HFD mice showed delayed gastric emptying and higher levels of gastric OEA. HFD-induced increase in OEA levels was accompanied by increased expression of the OEA-synthesizing enzyme N-acyl-phosphatidylethanolamine-selective phospholipase D and decreased expression of the OEA-degrading enzyme fatty acid amide hydrolase. These results might suggest that elevation of gastric OEA could possibly contribute to the delayed gastric emptying observed in HFD-fed animals. HFD regulates OEA levels in the stomach through an increase of its biosynthesis and a decrease of its enzymatic degradation. The inhibitory effect of OEA on gastric emptying here observed might underlie part of the anorexic effects of this compound previously reported.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18278475     DOI: 10.1007/s00109-008-0305-7

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  42 in total

Review 1.  The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract.

Authors:  Federico Massa; Martin Storr; Beat Lutz
Journal:  J Mol Med (Berl)       Date:  2005-08-26       Impact factor: 4.599

Review 2.  Interactions between gastric emptying and satiety, with special reference to glucagon-like peptide-1.

Authors:  P M Hellström; E Näslund
Journal:  Physiol Behav       Date:  2001 Nov-Dec

3.  Endocannabinoid overactivity and intestinal inflammation.

Authors:  V Di Marzo; A A Izzo
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

4.  Modulation of meal pattern in the rat by the anorexic lipid mediator oleoylethanolamide.

Authors:  Silvana Gaetani; Fariba Oveisi; Daniele Piomelli
Journal:  Neuropsychopharmacology       Date:  2003-04-02       Impact factor: 7.853

5.  Food intake regulates oleoylethanolamide formation and degradation in the proximal small intestine.

Authors:  Jin Fu; Giuseppe Astarita; Silvana Gaetani; Janet Kim; Benjamin F Cravatt; Ken Mackie; Daniele Piomelli
Journal:  J Biol Chem       Date:  2006-11-22       Impact factor: 5.157

6.  An anorexic lipid mediator regulated by feeding.

Authors:  F Rodríguez de Fonseca; M Navarro; R Gómez; L Escuredo; F Nava; J Fu; E Murillo-Rodríguez; A Giuffrida; J LoVerme; S Gaetani; S Kathuria; C Gall; D Piomelli
Journal:  Nature       Date:  2001-11-08       Impact factor: 49.962

7.  Oleoylethanolamide excites vagal sensory neurones, induces visceral pain and reduces short-term food intake in mice via capsaicin receptor TRPV1.

Authors:  Xiangbin Wang; Rosa Linda Miyares; Gerard P Ahern
Journal:  J Physiol       Date:  2005-02-03       Impact factor: 5.182

Review 8.  TRPV1 and the gut: from a tasty receptor for a painful vanilloid to a key player in hyperalgesia.

Authors:  Peter Holzer
Journal:  Eur J Pharmacol       Date:  2004-10-01       Impact factor: 4.432

9.  Intestinal levels of anandamide and oleoylethanolamide in food-deprived rats are regulated through their precursors.

Authors:  Gitte Petersen; Camilla Sørensen; Patricia C Schmid; Andreas Artmann; Mads Tang-Christensen; Steen H Hansen; Philip Just Larsen; Harald H O Schmid; Harald S Hansen
Journal:  Biochim Biophys Acta       Date:  2006-01-26

10.  Analgesic properties of oleoylethanolamide (OEA) in visceral and inflammatory pain.

Authors:  Margarita Suardíaz; Guillermo Estivill-Torrús; Carlos Goicoechea; Ainhoa Bilbao; Fernando Rodríguez de Fonseca
Journal:  Pain       Date:  2007-04-20       Impact factor: 6.961

View more
  22 in total

Review 1.  The gut-brain dopamine axis: a regulatory system for caloric intake.

Authors:  Ivan E de Araujo; Jozélia G Ferreira; Luis A Tellez; Xueying Ren; Catherine W Yeckel
Journal:  Physiol Behav       Date:  2012-03-03

2.  Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice.

Authors:  Angelo A Izzo; Raffaele Capasso; Gabriella Aviello; Francesca Borrelli; Barbara Romano; Fabiana Piscitelli; Laura Gallo; Francesco Capasso; Pierangelo Orlando; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

3.  Gastric electrical stimulation optimized to inhibit gastric motility reduces food intake in dogs.

Authors:  Geng-Qing Song; Hongbing Zhu; Yong Lei; Charlene Yuan; Warren Starkebaum; Jieyun Yin; Jiande D Z Chen
Journal:  Obes Surg       Date:  2015-06       Impact factor: 4.129

4.  Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB₁ receptors and TRPV1 channels.

Authors:  Raffaele Capasso; Pierangelo Orlando; Ester Pagano; Teresa Aveta; Lorena Buono; Francesca Borrelli; Vincenzo Di Marzo; Angelo A Izzo
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

5.  Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity.

Authors:  Zhongyi Chen; Lilu Guo; Yongqin Zhang; Rosemary L Walzem; Julie S Pendergast; Richard L Printz; Lindsey C Morris; Elena Matafonova; Xavier Stien; Li Kang; Denis Coulon; Owen P McGuinness; Kevin D Niswender; Sean S Davies
Journal:  J Clin Invest       Date:  2014-06-24       Impact factor: 14.808

Review 6.  Biological functions and metabolism of oleoylethanolamide.

Authors:  Clémentine Thabuis; Delphine Tissot-Favre; Jean-Baptiste Bezelgues; Jean-Charles Martin; Cristina Cruz-Hernandez; Fabiola Dionisi; Frédéric Destaillats
Journal:  Lipids       Date:  2008-08-13       Impact factor: 1.880

7.  Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding.

Authors:  Angelo A Izzo; Fabiana Piscitelli; Raffaele Capasso; Gabriella Aviello; Barbara Romano; Francesca Borrelli; Stefania Petrosino; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

8.  The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet.

Authors:  V Di Marzo; R Capasso; I Matias; G Aviello; S Petrosino; F Borrelli; B Romano; P Orlando; F Capasso; A A Izzo
Journal:  Br J Pharmacol       Date:  2008-01-28       Impact factor: 8.739

Review 9.  A fatty gut feeling.

Authors:  Daniele Piomelli
Journal:  Trends Endocrinol Metab       Date:  2013-04-06       Impact factor: 12.015

Review 10.  An update on PPAR activation by cannabinoids.

Authors:  Saoirse Elizabeth O'Sullivan
Journal:  Br J Pharmacol       Date:  2016-05-19       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.